COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1203
https://www.valueinhealthjournal.com/article/S1098-3015(15)03279-9/fulltext
Title :
COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03279-9&doi=10.1016/j.jval.2015.09.1203
First page :
A463
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
708